MAPT and Alzheimer disease: Disease‐related changes were relatively similar in AD‐tau/sham and AD‐tau/Aβ groups, confirming neuropathological findings suggesting that oligomeric Aβ injections had a limited impact on early seeding, spreading, and inflammatory events.